(PharmaNewsWire.Com, April 06, 2017 ) The prominent players in the wound care market include 3M Company (U.S.), Baxter International, Inc. (U.S.), Coloplast A/S (Denmark.), Convatec Healthcare B.S.A.R.L (U.S.), Covidien PLC (Ireland), Derma Sciences, Inc. (U.S.), Ethicon, Inc. (U.S.), Hollister, Inc. (U.S.), Kinetic Concept, Inc. (U.S.), Mölnlycke Health Care (Sweden), and Smith & Nephew (U.K.). <||>rnhttp://www.marketsandmarkets.com/Market-Reports/wound-care-market-371.html
The wound care market is highly fragmented and is divided into various segments. Each segment possesses different market players and market leaders. For instance, the traditional and basic wound care market was led by Ethicon in 2013. Ethicon is a subsidiary of Johnson & Johnson and offers an exhaustive product portfolio in the traditional wound care. Ethicon’s product portfolio consists of various wound products such as tissue control devices, sutures (absorbable and non absorbable), suture needles, suture cannula combination, suture assist devices, and skin staples. The company invests heavily in R&D, which helps it introduce technologically advanced products in the market.
Smith & Nephew led the advanced and the bio-active wound care market in 2013. The company leverages its strong brand name and has a strong presence in the market, which gives it a competitive edge over other players present in the market. The company is innovation centric and invests heavily in R&D for maintaining its market share. Moreover, the company possesses a strong sales force which helps it to sell its products efficiently. The company believes in both organic as well as inorganic growth for enhancing its market position. In November 2012, the company acquired assets of Healthcare bio therapeutics (U.S.), a biopharmaceutical company for $782 million. This acquisition enabled Smith & Nephew to incorporate the portfolio of Healthpoint biotherapeutics into its business which strengthened its bio-active wound care product offerings. Furthermore, in November 2013, Smith& Nephew acquired Politec Saude (Brazil), the only distributor of Smith & Nephew’s products in Brazil. This acquisition enabled the company to strengthen its distribution network in the Brazilian market, which possesses a strong growth opportunity for the company.
The key strategies followed by most companies in the wound care market are new product launches; agreements, collaborations, and partnerships; acquisitions; and expansions. Among all growth strategies being adopted by the market players in this field, new products launches accounted for the largest share of the overall growth strategies mapped from 2011 to 2014, in order to leverage the wound care market growth opportunities. Some leading players adopting the new product launches strategy include 3M Company (U.S.), Baxter International Inc, (U.S.), ConvaTec B.S.A.R.L. (Luxemburg), Covidien PLC (Ireland), Derma Sciences, Inc. (U.S.), Ethicon Inc. (U.S.), Kinetic Concepts Inc., (U.S.), Smith & Nephew (U.K.), and Mölnlycke Healthcare AB (Sweden). Acquisitions accounted for the second largest share of the overall growth strategies adopted by players in the market.
About MarketsandMarkets™ MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
